Synthetic Biology Solutions

1. Industry Background

Synthetic biology applies engineering principles to design and optimize biological systems for efficient biomanufacturing. It is transforming industries such as chemicals, pharmaceuticals, food, agriculture, and advanced materials. Applications continue to expand, from amino acids and organic acids to biofuels, recombinant proteins, and natural products.

Efficient engineering of microbial chassis cells is central to synthetic biology. Traditional homologous recombination methods are often inefficient and time-consuming. CRISPR-based genome editing has significantly accelerated strain development, enabling multiplex gene modifications and precise metabolic pathway control.

2. Industry Challenges

(1) Chassis Cell Engineering
Low efficiency of homologous recombination and high screening workload.
Limited capability for multiplex genome editing, leading to long development cycles.
Editing tools vary across microbial species, with poor universality.

(2) Metabolic Pathway Optimization
Target product synthesis involves multiple genes requiring coordinated regulation.
System-level challenges include precursor supply, cofactor balance, and product toxicity.
Lack of high-throughput methods for genotype–phenotype mapping.

(3) Strain Screening and Evaluation
Low throughput in high-yield strain screening.
Limited methods for genome-level stability assessment.
Genetic instability during industrial scale-up.

(4) Phage Engineering
Immature technologies for phage genome engineering.
Lack of standardized safety evaluation frameworks for phage therapy.

3. Solution Overview

GeneRulor leverages a mature microbial genome engineering platform to deliver an end-to-end solution for synthetic biology, encompassing chassis cell construction, metabolic engineering, high-throughput screening, and genome stability assessment.

Our solutions support diverse microbial systems, including bacteria, yeast, fungi, and bacteriophages.